Trial intelligence / Profile preview

Comparison of Pidrolax + Sepipic versus Sepipic alone for bowel preparation before colonoscopy

IRCT20230314057717N4Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of macrogol 4000 (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started May 2026; status: completed.

02

Drugs

macrogol 4000

Beyond the preview

Go deeper on IRCT20230314057717N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230314057717N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call